Beta Drugs Ltd
BETA (NSE)

510.00

490.59
Proj. ROE (%)
-
Proj. P/E (x)
-
Proj EV / EBITDA (x)
-
Proj. P/BV (x)
-
Proj. Revenue ( Cr.)
-

Stock View

-
Share on
The average score for Beta Drugs Ltd stands at against , three months back.

Beta Drugs Limited is an India-based pharmaceutical formulation manufacturing company. The Company is engaged in developing, manufacturing and marketing of drug products for domestic and international customers. The Company also engaged manufacturing oncology products. The Company offers a range of products including anti-cancer tablets, capsules, injections and lyophilized injections. The Company’s portfolio over 50 products catering to various oncology diseases including breast, brain, bone, lung, mouth,head, and neck,prostate, haematology, cervics, and oeaophagus. The Company’s oncology portfolio includes brands like Admine, Adgef, Addplatin, and Erlotad.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
524.58
100 DMA ()
447.12
200 DMA ()
321.24
52 Weeks Range
104.80
665.00
Street View :-
Bearish
Open ZERO Brokerage Demat Account
Open ZERO Brokerage Demat Account

  • 0

    Delivery Brokerage for Lifetime

  • 20

    Per order for Intraday, F&O, Currency & Commodity